---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-076333"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:41:57.589729+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics dismisses RSM, engages Cherry Bekaert as auditor

## Summary
- Dismissed RSM US LLP as independent auditor on June 19, 2024; no disagreements reported.
- Appointed Cherry Bekaert LLP as successor independent auditor effective June 19, 2024.
- RSM's reports for FY 2023 and 2022 included going concern qualification.
- Change approved by Audit Committee; no reportable events in prior periods.

## SEC filing metadata
- accession: 0000950170-24-076333
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017024076333/0000950170-24-076333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017024076333/tcrt-20240619.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-076333
- JSON: https://secwatch.observer/filing/0000950170-24-076333.json
- Plain text: https://secwatch.observer/filing/0000950170-24-076333.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.